In a landmark advancement for diabetes research, scientists have officially classified a long-overlooked condition as type 5 diabetes — a form linked to childhood malnutrition that affects an estimated 20 to 25 million people worldwide.
Predominantly seen across Asia and Africa, this newly recognised type — also known as malnutrition-related diabetes — highlights the profound impact of early-life undernutrition on lifelong health.
Furthermore, as global understanding of diabetes deepens, recognising type 5 diabetes could transform diagnosis, treatment, and prevention strategies, especially in low-resource regions where the condition often goes undetected.
Traditionally, diabetes has been divided into well-known categories, but research now reveals a far more complex landscape:
- Type 1 diabetes occurs when the immune system destroys insulin-producing pancreatic cells, resulting in dangerously high blood sugar and possible ketoacidosis.
- Type 2 diabetes, the most common form, stems from insulin resistance or reduced production, often linked to genetics and lifestyle.
- Gestational diabetes arises during pregnancy when hormonal shifts impair insulin function.
- Rarer variants, sometimes labelled type 3 or type 4, result from genetic mutations or other underlying diseases.
Type 5 diabetes breaks from these moulds entirely. It is not autoimmune like type 1, nor driven by insulin resistance like type 2. Instead, it involves low insulin secretion due to early pancreatic damage, demanding a distinct clinical approach.
Key Characteristics of Type 5 Diabetes
Type 5 diabetes results from insufficient insulin production, though the body’s cells still respond effectively to insulin when administered externally. Patients are typically underweight with a history of chronic childhood undernutrition, which stunts pancreatic beta-cell development.
Unlike type 2 diabetes, obesity is rare. Instead, this condition reflects environmental and socioeconomic hardship. Patients often produce small but inadequate amounts of insulin — enough to avoid complete dependency like type 1 patients, yet insufficient for stable glucose control.
Common symptoms include:
- Persistent high blood sugar
- Fatigue and unexplained weight loss
- Excessive thirst and urination
- Blurred vision and slow-healing wounds
These signs often appear in young adulthood, distinguishing it from the later onset of type 2 diabetes.
Historical Roots: From “Type J” to Type 5
The origins of type 5 diabetes trace back more than 70 years. In the 1950s, British physician Philip Hugh-Jones documented 13 patients in Jamaica who defied traditional classifications — lean individuals with insulin deficiency but no resistance. He named the condition “type J” diabetes, but the concept faded as global attention centred on types 1 and 2.
Decades later, the YODA (Young-Onset Diabetes in sub-Saharan Africa) study reignited interest. Analysing nearly 900 young adults across Cameroon, Uganda, and South Africa, researchers found that two-thirds lacked autoimmune markers typical of type 1, yet had insulin levels far below type 2 patients. This confirmed a unique, non-autoimmune insulin-deficient profile — now formally recognised as type 5 diabetes.
Causes: The Impact of Childhood Malnutrition
The primary cause is chronic early-life undernutrition. In areas plagued by food insecurity, prolonged calorie deficits impair pancreatic development, permanently weakening beta-cell capacity. This damage cannot be reversed later in life, even with improved nutrition.
Unlike genetically driven rare forms, type 5 diabetes is environmental — a disease born from poverty and food scarcity.
Diagnosing Type 5 Diabetes
Diagnosis remains challenging because symptoms overlap with other types. However, clinicians can identify it through several key markers:
- Blood Glucose and HbA1c Tests: Confirm persistent hyperglycaemia.
- Autoantibody Screening: Negative results rule out autoimmune type 1.
- C-Peptide Levels: Show reduced but detectable insulin production.
- Patient History: Undernutrition during childhood and low BMI provide vital clues.
Findings from the YODA study have refined these diagnostic parameters, urging healthcare systems to look beyond the standard classifications.
Managing Type 5 Diabetes: Treatment and Support
Treatment aligns most closely with type 1 protocols, as patients respond well to external insulin. However, careful dosing is critical to avoid hypoglycaemia, particularly where food access is uncertain.
Management essentials:
- Insulin therapy – personalised basal-bolus regimens adapted to dietary patterns.
- Regular monitoring – frequent blood sugar checks to maintain balance.
- Nutritional rehabilitation – gradual, supervised refeeding to prevent complications like refeeding syndrome.
- Lifestyle guidance – light physical activity and stress control to enhance insulin efficiency.
Basically, the recognition of type 5 diabetes underscores that diabetes is not a single disease, but a spectrum influenced by both biology and environment. Early nutritional interventions in vulnerable populations could prevent countless cases, while advanced diagnostics may ensure affected individuals receive proper care.
For the millions already living with this form of diabetes, the official naming brings hope — a chance for targeted treatment, greater awareness, and a fairer shot at long-term health.
Disclaimer:
This article summarises current medical research for educational purposes and should not replace professional medical advice. Always consult a qualified healthcare provider for personal guidance.
What are your thoughts on this new development? Be sure to let us know below.
Don’t forget to read, Eye care breakthroughs: the technology helping doctors save sight sooner, if you missed it.
FAQs: Type 5 diabetes
Type 5 diabetes, also known as malnutrition-related diabetes, is a newly recognised form of the disease caused by early-life undernutrition. It leads to low insulin production due to stunted pancreatic development rather than autoimmune damage or insulin resistance.
Unlike type 1 diabetes, type 5 diabetes is not caused by the immune system attacking the pancreas. Unlike type 2, it is not linked to obesity or insulin resistance. Instead, it stems from early nutritional deprivation that permanently impairs insulin production.
Individuals who experienced chronic childhood malnutrition are most at risk, particularly in low-income regions of Africa and Asia where food insecurity is widespread. The condition often appears in young adulthood.
Currently, there is no cure for type 5 diabetes. However, with careful insulin management, proper nutrition, and medical monitoring, individuals can control blood sugar levels and prevent complications.
Doctors diagnose type 5 diabetes using a combination of tests, including blood glucose and HbA1c, C-peptide levels (to assess insulin production), and antibody screening (to rule out autoimmune diabetes). A history of malnutrition and low body weight further supports the diagnosis.
Common symptoms include fatigue, unexplained weight loss, persistent thirst, frequent urination, blurred vision, and slow-healing wounds. Unlike type 2 diabetes, most patients are lean rather than overweight.
Treatment typically involves insulin therapy, careful monitoring of blood glucose, and nutritional rehabilitation to stabilise metabolism. Because food availability can be inconsistent in affected regions, dosing must be managed with extra caution.
Although first described in the 1950s as “type J” diabetes, it was largely overlooked until modern research — particularly the YODA study in Africa — confirmed it as a distinct condition. In 2025, international experts formally recognised it as type 5 diabetes.
It is estimated that between 20 and 25 million people worldwide may have type 5 diabetes, with the highest prevalence in Asia and sub-Saharan Africa.
Prevention focuses on improving childhood nutrition, food security, and early healthcare access. Ensuring balanced diets and adequate calorie intake during early development can protect pancreatic function and reduce the risk later in life.
